[go: up one dir, main page]

MXPA03002901A - Propionic acid derivatives with ppar-alpha activating properties. - Google Patents

Propionic acid derivatives with ppar-alpha activating properties.

Info

Publication number
MXPA03002901A
MXPA03002901A MXPA03002901A MXPA03002901A MXPA03002901A MX PA03002901 A MXPA03002901 A MX PA03002901A MX PA03002901 A MXPA03002901 A MX PA03002901A MX PA03002901 A MXPA03002901 A MX PA03002901A MX PA03002901 A MXPA03002901 A MX PA03002901A
Authority
MX
Mexico
Prior art keywords
ppar
propionic acid
acid derivatives
activating properties
alpha activating
Prior art date
Application number
MXPA03002901A
Other languages
Spanish (es)
Inventor
Hilmar Bischoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10124905A external-priority patent/DE10124905A1/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MXPA03002901A publication Critical patent/MXPA03002901A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
MXPA03002901A 2000-10-05 2001-09-24 Propionic acid derivatives with ppar-alpha activating properties. MXPA03002901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10049208 2000-10-05
DE10124905A DE10124905A1 (en) 2000-10-05 2001-05-22 propionic acid derivatives
PCT/EP2001/011005 WO2002028821A2 (en) 2000-10-05 2001-09-24 Propionic acid derivatives with ppar-alpha activating properties

Publications (1)

Publication Number Publication Date
MXPA03002901A true MXPA03002901A (en) 2003-10-15

Family

ID=26007267

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002901A MXPA03002901A (en) 2000-10-05 2001-09-24 Propionic acid derivatives with ppar-alpha activating properties.

Country Status (22)

Country Link
EP (1) EP1328508A2 (en)
JP (1) JP2004510757A (en)
CN (1) CN1479716A (en)
AU (1) AU2001293838A1 (en)
BG (1) BG107684A (en)
BR (1) BR0114437A (en)
CA (1) CA2424540A1 (en)
CZ (1) CZ2003964A3 (en)
EE (1) EE200300140A (en)
HN (1) HN2001000223A (en)
HR (1) HRP20030346A2 (en)
HU (1) HUP0302306A3 (en)
IL (1) IL155125A0 (en)
MA (1) MA25917A1 (en)
MX (1) MXPA03002901A (en)
NO (1) NO20031517L (en)
NZ (1) NZ525119A (en)
PL (1) PL361162A1 (en)
RU (1) RU2003112968A (en)
SK (1) SK4132003A3 (en)
UY (1) UY26951A1 (en)
WO (1) WO2002028821A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10151390A1 (en) * 2001-10-18 2003-05-08 Bayer Ag acetic acid derivatives
GB0214254D0 (en) 2002-06-20 2002-07-31 Glaxo Group Ltd Chemical compounds
WO2004037779A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes and their use
CA2502661A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes
CA2503405A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Treating syndrome x with substituted tetralins and indanes
EP1583754A1 (en) 2003-01-06 2005-10-12 Eli Lilly And Company Thiophene derivative ppar modulators
ES2754221T3 (en) 2003-08-29 2020-04-16 Ono Pharmaceutical Co Compound capable of binding the S1P receptor and pharmaceutical use thereof
AR048931A1 (en) 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv PROCESS FOR THE PREPARATION OF SUBSTITUTED AND INDIAN TETRALIN DERIVATIVES AND PREPARATION OF SYNTHESIS INTERMEDIARIES
CN100344618C (en) * 2004-05-24 2007-10-24 北京摩力克科技有限公司 N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
KR100699928B1 (en) 2004-10-05 2007-03-26 재단법인서울대학교산학협력재단 Method for preparing intermediates for the preparation of peroxysomal proliferator activated receptor alpha ligands
MX2007006916A (en) 2004-12-13 2007-08-06 Ono Pharmaceutical Co Aminocarboxylic acid derivative and medicinal use thereof.
CN101054372B (en) * 2006-04-11 2010-10-13 中国科学院上海药物研究所 Pyrimidine substituted benzenepropanoic acid derivative, its preparation method and use in curing polycystic kidney disease
KR101290868B1 (en) 2008-12-01 2013-07-29 미쓰비시 타나베 파마 코퍼레이션 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
JP5436941B2 (en) * 2009-06-03 2014-03-05 あすか製薬株式会社 Lactam compound or salt thereof and PPAR activator
UY34200A (en) 2011-07-21 2013-02-28 Bayer Ip Gmbh 3- (FLUOROVINIL) PIRAZOLES AND ITS USE
WO2016091746A1 (en) * 2014-12-11 2016-06-16 Dsm Sinochem Pharmaceuticals Netherlands B.V. Method for acylating a cyclic peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320387A1 (en) * 1973-04-21 1974-10-31 Boehringer Mannheim Gmbh PHENOXYALKYLCARBONIC ACID DERIVATIVES AND METHOD FOR PREPARING THE SAME
GB9822473D0 (en) * 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
HUP0302306A3 (en) 2005-02-28
HUP0302306A2 (en) 2003-10-28
RU2003112968A (en) 2004-09-20
WO2002028821A3 (en) 2002-08-15
UY26951A1 (en) 2002-06-20
NZ525119A (en) 2005-04-29
HRP20030346A2 (en) 2005-04-30
BG107684A (en) 2003-10-31
CA2424540A1 (en) 2003-04-02
EE200300140A (en) 2003-08-15
BR0114437A (en) 2003-07-01
WO2002028821A2 (en) 2002-04-11
IL155125A0 (en) 2003-10-31
AU2001293838A1 (en) 2002-04-15
PL361162A1 (en) 2004-09-20
EP1328508A2 (en) 2003-07-23
HN2001000223A (en) 2001-10-25
CN1479716A (en) 2004-03-03
SK4132003A3 (en) 2004-02-03
JP2004510757A (en) 2004-04-08
MA25917A1 (en) 2003-10-01
NO20031517D0 (en) 2003-04-03
NO20031517L (en) 2003-05-28
CZ2003964A3 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
HUP0201633A2 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
MXPA03004593A (en) Naphthalene derivatives.
MXPA03002269A (en) Purine derivatives.
AU1271201A (en) Azepinoindole derivatives, the production and use thereof
MXPA03000078A (en) Purine derivatives.
ZA200104196B (en) Azepinoindole derivatives, the production and use thereof.
AU2001230584A1 (en) 1h-imidazopyridine derivatives
ZA200410054B (en) Propionic acid derivatives and their use as hPPARsactivators.
MXPA03002901A (en) Propionic acid derivatives with ppar-alpha activating properties.
AU2001230537A1 (en) Pyridoxazine derivatives
ZA200207489B (en) Apomorphine derivatives and methods for their use.
AU2001284362A1 (en) Resorcinol derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
HUP0300857A3 (en) Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
HUP0204247A3 (en) Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
AU2001235437A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2001295815A1 (en) Multiple purpose catheter
AU2001293697A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof